BFRI today
$0.75-$0.18 (-19.17%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minExpanding
5 minStrong Bearish
Daily trend turns up above $1.01
Key levels
Resistance$0.86
Resistance$0.78
Support$0.65
Support$0.55
Latest news & SEC filings
EarningsBiofrontera Inc. Posts Q3 2026 Results
SEC FilingBiofrontera Inc. filed a report on a major company event (Form 8-K)
EarningsBiofrontera posts wider quarterly loss, revenue tops forecast
All BFRI news →About Biofrontera
Biofrontera is a US-based biopharmaceutical company that develops, manufactures, and sells treatments for dermatological conditions, focusing on photodynamic therapy. Its main offerings are Ameluz, a topical prescription drug, and a line of light-emitting lamps used alongside it to treat actinic keratosis, a skin condition involving pre-cancerous lesions. The company sells directly to dermatology practices and groups across the United States, and it also runs clinical research aimed at expanding its products' approved uses.
Based on the company's 10-K filed Mar 19, 2026.
Nasdaq · Healthcare
Biofrontera Inc. (BFRI)
What Is the Price Target for BFRI?
SEPT Low Target
$3.00
SEPT Mid Target
$3.00
SEPT High Target
$3.00
Analyst Consensus
$3.00
Is BFRI a Buy or Sell Right Now?
Thesis
- •Revenue growing 11.8% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BFRI.
Start Free Trial →Is BFRI Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$2.54
12
Moat Score
NONE
2/9
Piotroski Score
-5.5
Altman Z-Score
What Is Smart Money Doing with BFRI?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BFRI Growth Story
Revenue YoY
11.8%
3yr Revenue CAGR
13.3%
EPS Growth YoY
67.7%
FCF Growth YoY
-30.0%
Revenue Trend
STABLE
Dark Pool Trades for BFRI
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BFRI, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:17:51 | $0.74 | 1,000 | $$745 | SELL |
| 18:04:08 | $0.73 | 17,856 | $$13K | SELL |
| 17:55:57 | $0.75 | 1,000 | $$750 | BUY |
| 17:49:30 | $0.75 | 2,000 | $$2K | SELL |
| 17:48:06 | $0.76 | 1,520 | $$1K | BUY |
5 dark pool trades shown · $$17K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Biofrontera Inc. (BFRI) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BFRI — frequently asked questions
What is BFRI stock price today?
Biofrontera Inc. (BFRI) is at $0.75, down 19.17% (-$0.18) at the Nov 13, 2026 close.
Why is BFRI stock moving today?
Latest BFRI news — Nov 13, 2026: Biofrontera Inc. Posts Q3 2026 Results · Nov 13, 2026: Biofrontera Inc. filed a report on a major company event (Form 8-K)
What is the BFRI price target?
The average analyst price target for BFRI is $3.00, ranging from $3 to $3, based on 1 analysts. Latest: Benchmark downgrade on May 19, 2026.
What do analysts rate BFRI?
Analyst ratings for BFRI: 0 Buy, 0 Hold, 1 Sell — consensus Sell.
Did BFRI beat earnings?
BFRI last reported on Aug 13, 2026: EPS -$0.05 vs -$0.10 expected — a beat of 52.4%.
Does BFRI pay a dividend?
BFRI does not currently pay a dividend.
What are BFRI support and resistance levels?
Support: $0.65, $0.55. Resistance: $0.78, $0.86, $1.01.
What are insiders doing with BFRI?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on BFRI?
Nov 13, 2026: Biofrontera Inc. Posts Q3 2026 Results · Nov 13, 2026: Biofrontera Inc. filed a report on a major company event (Form 8-K) · Nov 13, 2026: Biofrontera posts wider quarterly loss, revenue tops forecast